Protecting patents after they expire

Multinational pharmaceutical companies are facing strains on their revenues as many of their patents covering their biggest selling medicines are due to expire. But in China an SPC ruling on pen designs has shown that other IP rights could come to the rescue

9 minute readSeptember 12, 2012 at 12:58 AM

clpstaff

& clp articles

The day after our on-site visit to one of Pfizer's plants in County Cork, Ireland, the US drug maker announced that it would cut 177 jobs there. The company said

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)